MedTrace Logo

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

NCT02567578 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-01-13

No results posted yet for this study

Summary

This is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2 trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia.

Conditions

  • Functional Dyspepsia

Interventions

DRUG

YH12852 0.1 mg

DRUG

YH12852 0.25 mg

DRUG

YH12852 0.5 mg

DRUG

Placebo

Sponsors & Collaborators

  • Yuhan Corporation

    lead INDUSTRY

Principal Investigators

  • Poong Lyul Lee, MD, Ph.D · Samsung seoul hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-03-16
Completion
2017-03-16

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567578 on ClinicalTrials.gov